Related Experiment Video
Updated: Aug 30, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
In-Hospital Hyperglycemia Is Associated With Worse Outcomes in Patients Admitted With COVID-19
Angela Lombardi1, Shivani Agarwal1, Clyde Schechter2
1Einstein-Mount Sinai Diabetes Research Center, The Norman Fleischer Institute for Diabetes and Metabolism, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.
Insights
Hyperglycemia in diabetic patients hospitalized with COVID-19 significantly increases mortality and the need for mechanical ventilation. Tight inpatient glycemic control may improve outcomes for these high-risk patients.
Area of Science:
- Internal Medicine
- Endocrinology
- Infectious Diseases
Background:
- Diabetes and outpatient glycemic control are known risk factors for sepsis complications.
- The impact of inpatient glycemic control on COVID-19 outcomes in diabetic patients remains unclear.
Purpose of the Study:
- To investigate the effect of inpatient hyperglycemia on outcomes in diabetic patients hospitalized with COVID-19.
Main Methods:
- Analysis of 1,938 diabetic COVID-19 patients from March-May 2020.
- Categorization into normoglycemic and hyperglycemic groups.
- Cox proportional hazards regression to assess mortality and mechanical ventilation risk.
Main Results:
- 68% of patients were hyperglycemic; 31% died, 14% required mechanical ventilation.
- Inpatient hyperglycemia was significantly associated with increased mortality and mechanical ventilation.
- Adjusted analysis showed uncontrolled hyperglycemia increased mortality risk (HR 1.54) and MV risk (HR 4.41).
Conclusions:
- Tight control of inpatient hyperglycemia may improve outcomes for diabetic patients hospitalized with COVID-19.
Objective:
Diabetes and the outpatient diabetes treatment regimen have been identified as risk factors for poor outcomes in patients with sepsis. However, little is known about the effect of tight inpatient glycemic control in the setting of coronavirus disease 2019 (COVID-19). Therefore, we examined the effect of hyperglycemia in patients with diabetes hospitalized because of COVID-19.
Research Design And Methods:
We analyzed data from 1,938 COVID-19 patients with diabetes hospitalized for COVID-19 from March to May 2020 at a large academic medical center in New York City. Patients were divided into two groups based on their inpatient glycemic values, and a Cox proportional hazards regression model was used to assess the independent association of inpatient glucose levels with mortality (primary outcome) and the risk of requiring mechanical ventilation (MV) (secondary outcome).
Results:
In our analysis, 32% of the patients were normoglycemic and 68% hyperglycemic. Moreover, 31% of the study subjects died during hospitalization, and 14% required MV, with inpatient hyperglycemia being significantly associated with both mortality and the requirement for MV. Additionally, in the Cox regression analysis, after adjustment for potential confounders, including age, sex, race, BMI, HbA1c, comorbidities, inflammatory markers, and corticosteroid therapy, patients with uncontrolled hyperglycemia had a higher risk of dying (hazard ratio [HR] 1.54, 95% CI 1.00-2.36, P = 0.049) and of requiring MV (HR 4.41, 95% CI 1.52-2.81, P = 0.006) than those with normoglycemia.
Conclusions:
A tight control of inpatient hyperglycemia may be an effective method for improving outcomes in patients with diabetes hospitalized for COVID-19.
More Related Videos
09:35A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Acute Pancreatitis II: Clinical Manifestations and Management
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...